The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Pyranistole 200 mg prolonged release capsules

Renata Pharmaceuticals (Ireland) LimitedPA22865/001/001

Main Information

Trade NamePyranistole 200 mg prolonged release capsules
Dosage FormProlonged-release capsule, hard
Licence HolderRenata Pharmaceuticals (Ireland) Limited
Licence NumberPA22865/001/001

Group Information

ATC CodeB01AC Platelet aggregation inhibitors excl. heparin
B01AC07 dipyridamole


License statusAuthorised
Licence Issued06/07/2018
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back